MergerLinks Header Logo

Submit Deal

Submit Deal

Cover Image Shreeram Aradhye
Shreeram AradhyeNOVARTIS AG

Shreeram Aradhye

President, Development and Chief Medical Officer at NOVARTIS AG

Manager

Deal Bio

Total Deals4
Valued Deals4
Total Value£ 7.11 B
Avg. Deal Size£ 1.78 B

Market Context

Sort

05 Feb 2024|Germany|Biotechnology
Morphosys
Novartis

Target: MORPHOSYS AG

Bidder: NOVARTIS AG

9 Service Providers

5 Target | 4 Bidder

103 Dealmakers

31 Target | 74 Bidder

£ 2.31 B

Value

11 Feb 2025|United States|Biotechnology
Anthos Therapeutics
Novartis

Target: ANTHOS THERAPEUTICS

Bidder: NOVARTIS AG

9 Service Providers

5 Target | 2 Bidder | 2 Vendor

30 Dealmakers

8 Target | 10 Bidder | 12 Vendor

£ 2.50 B

Value

30 Apr 2025|United States|Biotechnology
Regulus Therapeutics
Novartis

Target: REGULUS THERAPEUTICS

Bidder: NOVARTIS AG

5 Service Providers

3 Target | 2 Bidder

47 Dealmakers

32 Target | 15 Bidder

£ 1.27 B

Value

09 Sep 2025|United States|Biotechnology
Tourmaline Bio
Novartis

Target: TOURMALINE BIO INC

Bidder: NOVARTIS AG

6 Service Providers

5 Target | 1 Bidder

11 Dealmakers

10 Target | 1 Bidder

£ 1.03 B

Value

Privacy PolicyTerms of ServiceContact UsCookie Preferences

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Shreeram Aradhye